| 发明名称 |
TREATMENT OF CROHN'S DISEASE WITH DELAYED-RELEASE 6-MERCAPTOPURINE |
| 摘要 |
Methods of treating patients suffering from Crohn's disease or ulcerative colitis who did not experience a clinical response to previous thiopurine administration, or suffered side effects from previous thiopurine administration, by administering a delayed release pharmaceutical composition comprising 6-mercaptopurine are disclosed. Methods of treating patients suffering from Crohn's disease or ulcerative colitis who are also being administered a steroid, 5-aminosalicylic acid, or an antibiotic by adjunctively administering a delayed release pharmaceutical composition comprising 6-mercaptopurine are also disclosed. |
| 申请公布号 |
US2015313904(A1) |
申请公布日期 |
2015.11.05 |
| 申请号 |
US201514701201 |
申请日期 |
2015.04.30 |
| 申请人 |
KOLATCH Brenda;HOTOVELY-SALOMON Anna |
发明人 |
KOLATCH Brenda;HOTOVELY-SALOMON Anna |
| 分类号 |
A61K31/52;A61K9/00 |
主分类号 |
A61K31/52 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a human patient suffering from Crohn's disease (CD) or ulcerative colitis (UC) who did not experience a clinical response to previous thiopurine administration, comprising periodically administering to the human patient a delayed release pharmaceutical composition comprising a pharmaceutically acceptable carrier and an amount of 6-mercaptopurine (6-MP) effective to treat the human patient. |
| 地址 |
Jerusalem IL |
